TABLE 2.
The alteration of MDD diagnosis after the addition of pathological information.
| Pre-biopsy dx | Post-biopsy dx | p value | |
|---|---|---|---|
| UT-VATS (n = 67) | TBLC (n = 70) | ||
| IPF (n = 13) | IPF 8 | IPF 3 | 0.40 |
| RBILD/DIP 2 | – | ||
| COP (n = 1) | NA | COP 1 | – |
| RBILD/DIP (n = 7) | RBILD/DIP 2 | RBILD/DIP 2 | 0.15 |
| IPF 2 | – | ||
| HP 1 | – | ||
| LIP (n = 2) | NSIP 1 | LIP 1 | – |
| UIIP (n = 37) | UIIP 9 | UIIP 8 | 0.46 |
| HP 4 | IPF 3 | ||
| IPF 3 | NSIP 1 | ||
| RBILD/DIP 2 | Pneumoconiosis 1 | ||
| IPAF 1 | HP 1 | ||
| LIP 1 | ACIF 1 | ||
| Vasculitis 1 | – | ||
| ACIF 1 | – | ||
| IPAF (n = 34) | IPAF 12 | IPAF 20 | 0.10 |
| Sarcoidosis 1 | – | ||
| – | HP 1 | – | |
| CTD-ILD (n = 22) | CTD-ILD 9 | CTD-ILD 12 | 0.43 |
| – | IPF 1 | ||
| HP (n = 3) | IPAF 1 | HP 1 | – |
| – | Infection 1 | ||
| Sarcoidosis (n = 1) | Sarcoidosis 1 | NA | – |
| PAP (n = 5) | PAP 1 | PAP 4 | – |
| PLAM (n = 4) | NA | PLAM 4 | – |
| Vasculitis (n = 1) | Vasculitis 1 | NA | – |
| Pneumoconiosis (n = 1) | Lipid pneumonia 1 | – | – |
| PLCH (n = 2) | UIIP 1 | PLCH 1 | – |
| IPH (n = 1) | NA | IPH 1 | – |
| PAM (n = 1) | NA | PAM 1 | – |
| Infection (n = 1) | NA | Infection 1 | – |
UT-VATS: uniportal and tubeless-video-assisted thoracic surgery, TBLC: transbronchial lung cryobiopsy, IPF: idiopathic pulmonary fibrosis, NSIP: non-specific interstitial pneumonia, COP: cryptogenic organizing pneumonia, RB-ILD: respiratory bronchiolitis interstitial lung disease, DIP: desquamative interstitial pneumonia, LIP: lymphocyte interstitial pneumonia, ACIF: airway-lefted interstitial fibrosis, UIIP: undefined interstitial pneumonia, IPAF: interstitial pneumonia with autoimmune features, CTD-ILD: connective tissue disease-related ILD, HP: hypersensitivity pneumonitis, PAP: pulmonary alveolar proteinosis, PLAM: pulmonary lymphangioleiomyomatosis, PLCH: pulmonary Langerhans cell histiocytosis, IPH: idiopathic pulmonary hemosiderosis, PAM: pulmonary alveolar microlithiasis.